Find clinical trials for Multiple Myeloma in Detroit, MI
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Detroit, MI, USA:
This research study is studying a combination of study drugs as a possible treatment for relapsed and refractory Multiple Myeloma. ...
Phase 2
Ann Arbor, Michigan, United States and 5 other locations
A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
This research study is studying a targeted therapy as a possible treatment for multiple myeloma.The names of the study drugs involv...
Phase 1
Detroit, Michigan, United States and 1 other location
This research study is studying a drug as a possible treatment for Monoclonal Gammopathy of Unknown Significance (MGUS) or Smoldering Multiple...
Phase 2
Detroit, Michigan, United States and 5 other locations
The purpose of this study is to evaluate the safety and preliminary efficacy of CC-92480 in combination with standard treatments.
Phase 1, Phase 2
Detroit, Michigan, United States and 48 other locations
This study will be a multi-center, open-label, Phase 2 study where newly diagnosed Multiple Myeloma requiring systemic chemotherapy...
Phase 2
Ann Arbor, Michigan, United States and 2 other locations
The purpose of this research study is to evaluate a treatment regimen called IRD which will be given to participants after their stem cell transplant...
Phase 2
Detroit, Michigan, United States and 9 other locations
versus standard regimens in subjects with relapsed and refractory multiple myeloma (RRMM).The study is anticipated to randomize app...
Phase 3
Ann Arbor, Michigan, United States and 59 other locations
versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in newly diagnosed multiple...
Phase 3
Detroit, Michigan, United States and 126 other locations
doses) of the study medicine (elranatamab) in participants with multiple myeloma that has come back after responding to treatment o ...
Phase 2
Detroit, Michigan, United States and 42 other locations
This study is a first-in-human, Phase 1/2, open label study that will evaluate safety and efficacy of ISB 1442 in relapsed/refractory multiple...
Phase 1, Phase 2
Detroit, Michigan, United States and 14 other locations
Clinical trials
Research sites
Resources
Legal